Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

KYKYNB
5 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in KYNTRA BIO INC

Yes. JPMorgan Chase holds 12 shares of KYNB (Kyntra Bio), worth $88, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held KYNB in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$88

Current Shares

12

Total Value Change

+$24

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
12
0.0%
$880.0%$7.55
0
2026-Q1
Unchanged
12
0.0%
$780.0%$6.78
0
2025-Q4
Unchanged
12
0.0%
$1050.0%$8.78
0
2025-Q3
Unchanged
12
0.0%
$1470.0%$12.25
0
2025-Q2
New
12
-
$640.0%$5.30
17

Other major holders of KYNB: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used